4.5 Article

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis

期刊

ARTHRITIS & RHEUMATOLOGY
卷 70, 期 8, 页码 1319-1330

出版社

WILEY
DOI: 10.1002/art.40498

关键词

-

资金

  1. Arthritis Research UK [20542]
  2. SPARKSUK [08ICH09, 12ICH08]
  3. Medical Research Council [MR/M004600/1]
  4. NIHR Biomedical Research Centres at Great Ormond Street Hospital for Children National Health Service Foundation Trust
  5. University College London Hospitals Trust
  6. NIHR-Clinical Research Network
  7. Canadian Institutes of Health Research (CIHR)
  8. Arthritis Society (CIHR) [82517]
  9. Canadian Arthritis Network [SRI-IJD-01]
  10. Cincinnati Children's Research Foundation and its Cincinnati Genomic Control Cohort
  11. Wellcome Trust [076113/C/04/Z]
  12. US NIH [RP-PG-0310-1002]
  13. British 1958 Birth Cohort collection
  14. UK Medical Research Council [G0000934]
  15. Wellcome Trust grant [068545/Z/02]
  16. MRC [MR/R013926/1, MR/M004600/1] Funding Source: UKRI
  17. Great Ormond Street Hospital Childrens Charity [V1304] Funding Source: researchfish
  18. Medical Research Council [MR/R013926/1, MR/M004600/1] Funding Source: researchfish
  19. National Institute for Health Research [NF-SI-0616-10099] Funding Source: researchfish
  20. Versus Arthritis [20542] Funding Source: researchfish

向作者/读者索取更多资源

Objective. To determine whether systemic juvenile idiopathic arthritis (JIA) susceptibility loci that were identified by candidate gene studies demonstrate association with systemic JIA in the largest study population assembled to date. Methods. Single-nucleotide polymorphisms (SNPs) from 11 previously reported systemic JIA risk loci were examined for association in 9 populations, including 770 patients with systemic JIA and 6,947 controls. The effect of systemic JIA-associated SNPs on gene expression was evaluated in silico in paired whole genome and RNA sequencing data from the lymphoblastoid cell lines (LCLs) of 373 European subjects from the 1000 Genomes Project. Responses of systemic JIA-associated SNPs to anakinra treatment were evaluated in 38 US patients for whom treatment response data were available. Results. We found no association between the previously reported 26 SNPs and systemic JIA. Expanded analysis of the regions containing the 26 SNPs revealed only 1 significant association: the promoter region of IL1RN (P < 1 x 10(-4)). Systemic JIA-associated SNPs correlated with IL1RN expression in LCLs, with an inverse correlation between systemic JIA risk and IL1RN expression. The presence of homozygous IL1RN high expression alleles correlated strongly with a lack of response to anakinra therapy (odds ratio 28.7 [95% confidence interval 3.2-255.8]). Conclusion. In our study, IL1RN was the only candidate locus associated with systemic JIA. The implicated SNPs are among the strongest known determinants of IL1RN and interleukin-1 receptor antagonist levels, linking low expression with increased systemic JIA risk. Homozygous high expression alleles predicted nonresponsiveness to anakinra therapy, making them ideal candidate biomarkers to guide systemic JIA treatment. This study is an important first step toward the personalized treatment of systemic JIA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Rheumatology

Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers

Pedro M. Machado, Martin Schaefer, Anja Strangfeld, Laure Gossec, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F. Mateus, Loreto Carmona, Kimme L. Hyrich, Philip C. Robinson, Jinoos Yazdany

ANNALS OF THE RHEUMATIC DISEASES (2023)

Letter Rheumatology

Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al

Martin Schaefer, Anja Strangfeld, Kimme L. Hyrich, Loreto Carmona, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F. Mateus, Laure Gossec, Philip C. Robinson, Jinoos Yazdany, Pedro M. Machado

ANNALS OF THE RHEUMATIC DISEASES (2023)

Letter Rheumatology

Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al

Kimme L. Hyrich, Martin Schaefer, Anja Strangfeld, Loreto Carmona, Laure Gossec, Elsa F. Mateus, Saskia Lawson-Tovey, Milena Gianfrancesco, Philip C. Robinson, Jinoos Yazdany, Pedro M. Machado

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B. McInnes, Naveed Sattar, Tanja A. Stamm, Tsutomu Takeuchi, Michael Trauner, Desiree van der Heijde, Marieke Voshaar, Kevin L. Winthrop, Angelo Ravelli, Neil Betteridge, Gerd-Ruediger R. Burmester, Johannes W. J. Bijlsma, Vivian Bykerk, Roberto Caporali, Ernest H. Choy, Catalin Codreanu, Bernard Combe, Mary K. Crow, Maarten de Wit, Paul Emery, Roy M. Fleischmann, Cem Gabay, Merete Lund Hetland, Kimme L. Hyrich, Annamaria Iagnocco, John D. Isaacs, Joel M. Kremer, Xavier Mariette, Peter Merkel, Eduardo F. Mysler, Peter Nash, Michael T. Nurmohamed, Karel Pavelka, Gyula Poor, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S. Smolen

Summary: This paper is an updated consensus document on the medical use of IL-6 pathway inhibition in the treatment of inflammatory diseases. The document provides comprehensive consensus statements based on systematic literature research and expert opinion, covering various aspects of IL-6 pathway inhibitors, including dosing, indications, and clinical considerations.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Chronic Anterior Uveitis

Ivan Foeldvari, Ilaria Maccora, Harry Petrushkin, Najiha Rahman, Jordi Anton, Joke de Boer, Joan Calzada-Hernandez, Elisa Carreras, Jesus Diaz, Clive Edelsten, Sheila T. Angeles-Han, Arnd Heiligenhaus, Elisabetta Miserocchi, Susan Nielsen, Rotraud K. Saurenmann, Nicole Stuebiger, Karoline Baquet-Walscheid, Daniel Furst, Gabriele Simonini

Summary: The Multinational Interdisciplinary Working Group for Uveitis in Childhood recognized the need to update current guidelines for managing children with juvenile idiopathic arthritis-associated uveitis (JIAU) and idiopathic chronic anterior uveitis (CAU). After analyzing literature and conducting a consensus meeting, 14 recommendations for JIAU and CAU treatment were accepted with over 90% agreement. This evidence-based consensus process aims to provide an updated guideline to support clinicians in caring for children and young people with CAU.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries

Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gomez-Reino, Kim Lauper, Denis Mongin, Florenzo Iannone, Karel Pavelka, Dan C. Nordstrom, Nevsun Inanc, Catalin Codreanu, Kimme L. Hyrich, Denis Choquette, Anja Strangfeld, Burkhard F. Leeb, Ziga Rotar, Ana Rodrigues, Eirik Klami Kristianslund, Tore K. Kvien, Ori Elkayam, Galina Lukina, Sytske Anne Bergstra, Axel Finckh, Delphine Sophie Courvoisier

Summary: The objective of this study was to compare the effectiveness of cycling Janus kinase inhibitors (JAKi) with switching to biologic disease-modifying antirheumatic drug (bDMARD) in patients with rheumatoid arthritis (RA). The results showed that both strategies had similar observed drug retention rates after 2 years, but cycling JAKi was associated with higher retention after adjusting for confounders. It was also found that if the first JAKi was discontinued due to an adverse event (AE), it was more likely that the second JAKi would also be stopped due to an AE. Improvement in Clinical Disease Activity Index (CDAI) over time was similar in both strategies.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Allergy

Proinflammatory polarization of monocytes by particulate air pollutants is mediated by induction of trained immunity in pediatric asthma

Hesam Movassagh, Mary Prunicki, Abhinav Kaushik, Xiaoying Zhou, Diane Dunham, Eric M. M. Smith, Ziyuan He, German R. Aleman R. Muench, Minyi Shi, Annika K. K. Weimer, Shu Cao, Sandra Andorf, Amir Feizi, Michael P. P. Snyder, Pejman Soroosh, Elizabeth D. D. Mellins, Kari C. C. Nadeau

Summary: This study found that exposure to fine particulate matter (PM2.5) leads to specific alterations in monocytes, especially in children with asthma. Further mechanistic research revealed that fine particulate matter induces innate trained immunity in circulating monocytes, resulting in an enhanced inflammatory response. These findings suggest that the alterations of monocytes may serve as an immune signature for pediatric asthma, and pollution-induced trained immunity could be a potential therapeutic target for asthmatic children.

ALLERGY (2023)

Article Genetics & Heredity

Great expectations: patients' preferences for clinically significant results from genomic sequencing

Salma Shickh, Agnes H. Sebastian, Marc Clausen, Chloe Mighton, Christine F. Elser, Andrea Eisen, Larissa Waldman, Seema Panchal, Thomas Ward, June E. Carroll, Emily Glogowski, Kasmintan Schrader, Jordan A. Lerner-Ellis, Raymond Kim, Kevin E. Thorpe, Yvonne Bombard

Summary: This study aimed to understand patient preferences and factors influencing preferences for secondary findings from genomic sequencing. The majority of adult cancer patients in the trial expressed interest in receiving various types of secondary findings, even those without immediate medical actionability. Older participants were more interested in early-onset neurological diseases, and those with lower decisional conflict were more likely to select all categories. The results emphasize the importance of incorporating patient preferences into guidelines on secondary findings.

HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

ANK2 loss-of-function variants are associated with epilepsy, and lead to impaired axon initial segment plasticity and hyperactive network activity in hiPSC-derived neuronal networks

Maria W. A. Teunissen, Elly Lewerissa, Eline J. H. van Hugte, Shan Wang, Charlotte W. Ockeloen, David A. Koolen, Rolph Pfundt, Carlo L. M. Marcelis, Eva Brilstra, Jennifer L. Howe, Stephen W. Scherer, Xavier Le Guillou, Frederic Bilan, Michelle Primiano, Jasmin Roohi, Amelie Piton, Anne de Saint Martin, Sarah Baer, Simone Seiffert, Konrad Platzer, Rami Abou Jamra, Steffen Syrbe, Jan H. Doering, Shenela Lakhani, Srishti Nangia, Christian Gilissen, R. Jeroen Vermeulen, Rob P. W. Rouhl, Han G. Brunner, Marjolein H. Willemsen, Nael Nadif Kasri

Summary: This study aimed to characterize a new neurodevelopmental syndrome caused by loss-of-function variants in ANK2 gene and explore the effects on neuronal network dynamics and homeostatic plasticity in human induced pluripotent stem cell-derived neurons. Clinical and molecular data of 12 individuals with heterozygous de novo loss-of-function variants in ANK2 were collected. HiPSCs with a heterozygous loss-of-function allele of ANK2 were generated using CRISPR/Cas9. Excitatory neurons were differentiated from these hiPSCs and their spontaneous electrophysiological responses were measured using micro-electrode arrays. Results showed a broad neurodevelopmental disorder with intellectual disability, autism spectrum disorders, and early onset epilepsy. HiPSC-derived neurons with ANK2 loss-of-function exhibited a hyperactive and desynchronized neuronal network, increased somatodendritic structures, and altered AIS structure with impaired activity-dependent plasticity.

HUMAN MOLECULAR GENETICS (2023)

Article Biochemistry & Molecular Biology

Gene copy number variation and pediatric mental health/neurodevelopment in a general population

Mehdi Zarrei, Christie L. Burton, Worrawat Engchuan, Edward J. Higginbotham, John Wei, Sabah Shaikh, Nicole M. Roslin, Jeffrey R. MacDonald, Giovanna Pellecchia, Thomas Nalpathamkalam, Sylvia Lamoureux, Roozbeh Manshaei, Jennifer Howe, Brett Trost, Bhooma Thiruvahindrapuram, Christian R. Marshall, Ryan K. C. Yuen, Richard F. Wintle, Lisa J. Strug, Dimitri J. Stavropoulos, Jacob A. S. Vorstman, Paul Arnold, Daniele Merico, Marc Woodbury-Smith, Jennifer Crosbie, Russell J. Schachar, Stephen W. Scherer

Summary: In a Canadian community sample of 7100 unrelated children and youth of European or East Asian ancestry, we found that gene copy number variation (CNV) is associated with mental health/neurodevelopmental traits and diagnoses, physical health, and cognition. Clinically significant or susceptibility CNVs were present in 3.9% of participants and were associated with elevated scores on attention-deficit/hyperactivity disorder (ADHD) traits, longer response inhibition, and increased prevalence of mental health diagnoses, specifically ADHD, autism spectrum disorder, anxiety, and learning problems/learning disorder. Our data also revealed an increased burden of rare deletions in gene-sets related to brain function associated with more ADHD traits. This study provides valuable insights into the genetic contributions to pediatric-onset conditions, especially in the current mental health crisis.

HUMAN MOLECULAR GENETICS (2023)

Review Genetics & Heredity

A model for the return and referral of all clinically significant secondary findings of genomic sequencing

Rita Kodida, Emma Reble, Marc Clausen, Salma Shickh, Chloe Mighton, Jordan Sam, Nicole Forster, Seema Panchal, Melyssa Aronson, Kara Semotiuk, Tracy Graham, Yael Silberman, Susan Randall Armel, Jeanna M. McCuaig, Iris Cohn, Chantal F. Morel, Christine Elser, Andrea Eisen, June C. Carroll, Emily Glogowski, Kasmintan A. Schrader, Vanessa Di Gioacchino, Jordan Lerner-Ellis, Raymond H. Kim, Yvonne Bombard, Incidental Genom Study Team

Summary: Secondary findings identified through genomic sequencing can provide various health benefits to patients, but resource and capacity constraints pose challenges to their clinical management. Clinical workflows are needed to optimize the benefits of these findings.

JOURNAL OF MEDICAL GENETICS (2023)

Article Developmental Biology

Evaluation of C4 gene copy number in Pediatric Acute Neuropsychiatric Syndrome

Agnieszka Kalinowski, Lu Tian, Reenal Pattni, Hanna Ollila, Maroof Khan, Cindy Manko, Melissa Silverman, Meiqian Ma, Laurie Columbo, Bahare Farhadian, Susan Swedo, Tanya Murphy, Mats Johnson, Elisabeth Fernell, Christopher Gillberg, Margo Thienemann, Elizabeth D. Mellins, Douglas F. Levinson, Alexander E. Urban, Jennifer Frankovich

Summary: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a sudden-onset neuropsychiatric disorder with an increased prevalence of co-morbid autoimmune illness, particularly arthritis. PANS patients with low C4B copy number are at higher risk for subsequent Juvenile Idiopathic Arthritis (JIA) diagnosis. There is a possible association between low C4B and PANS age of onset, suggesting a potential role of C4B in different types of arthritis.

DEVELOPMENTAL NEUROSCIENCE (2023)

Article Clinical Neurology

Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study

Alissa M. D'Gama, Sarah Mulhern, Beth R. Sheidley, Fadil Boodhoo, Sarah Buts, Natalie J. Chandler, Joanna Cobb, Meredith Curtis, Edwardj Higginbotham, Jonathon Holland, Tayyaba Khan, Julia Koh, Nicole S. Yliang, Lyndsey Mcrae, Sarah E. Nesbitt, Brandon T. Oby, Ben Paternoster, Alistair Patton, Graham Rose, Elizabeth Scotchman, Rozalia Valentine, Kimberly N. Wiltrout, Robin Z. Hayeems, Puneet Jain, Sebastian Lunke, Christian R. Marshall, Shira Rockowitz, Neilj Sebire, Zornitza Stark, Susan M. White, Lyn S. Chitty, J. Helen Cross, Ingrid E. Scheffer, Vann Chau, Gregory Costain, Annapurna Poduri, Katherine B. Howell, Amy McTague

Summary: A cohort study was conducted to determine the feasibility and clinical utility of rapid genome sequencing in infants with new-onset epilepsy. Among 100 infants enrolled in the study, genetic diagnoses were identified in 43% of the cases. Rapid genome sequencing had immediate clinical impact on treatment, evaluation, prognosis, and recurrence risk counselling.

LANCET NEUROLOGY (2023)

Correction Genetics & Heredity

A mutational hotspot in AMOTL1 defines a new syndrome of orofacial clefting, cardiac anomalies, and tall stature (vol 191A, 1227, 2023)

Alanna Strong, Soumya Rao, Sandra von Hardenberg, Dong Li, Liza L. Cox, Paul C. Lee, Li Q. Zhang, Waheed Awotoye, Tamir Diamond, Jessica Gold, Catherine Gooch, Lord Jephthah Joojo Gowans, Hakon Hakonarson, Anne Hing, Kathleen Loomes, Nicole Martin, Thanuja Selvanayagam, Mary L. Marazita, Tarja Mononen, David Piccoli, Rolph Pfundt, Salmo Raskin, Stephen W. Scherer, Nara Sobriera, Courtney Vaccaro, Xiang Wang, Deborah Watson, Rosanna Weksberg, Elizabeth Bhoj, Jeffrey C. Murray, Andrew C. Lidral, Azeez Butali, Michael F. Buckley, Tony Roscioli, David A. Koolen, Laurie H. Seaver, Cynthia A. Prows, Rolf W. Stottmann, Timothy C. Cox

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Cell Biology

Extracellular vesicles in systemic juvenile idiopathic arthritis

Justine Maller, Terry Morgan, Mayu Morita, Frank McCarthy, Yunshin Jung, Katrin J. Svensson, Joshua E. Elias, Claudia Macaubas, Elizabeth Mellins

Summary: The study suggests that intercellular communication mediated by extracellular vesicles plays an important role in the pathogenesis of systemic juvenile idiopathic arthritis. The number and cellular sources of extracellular vesicles differ between the active and inactive states of the disease and healthy controls.

JOURNAL OF LEUKOCYTE BIOLOGY (2023)

暂无数据